Banco de Sabadell’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $796K | Sell |
5,281
-389
| -7% | -$59.6K | 0.53% | 51 |
|
|
2025
Q4 | $781K | Sell |
5,670
-50
| -0.9% | -$6.55K | 0.51% | 51 |
|
|
2025
Q3 | $732K | Sell |
5,720
-1,216
| -18% | -$148K | 0.48% | 54 |
|
|
2025
Q2 | $839K | Buy |
6,936
+33
| +0.5% | +$3.72K | 0.58% | 53 |
|
|
2025
Q1 | $772K | Buy |
6,903
+51
| +0.7% | +$5.43K | 0.59% | 51 |
|
|
2024
Q4 | $670K | Sell |
6,852
-264
| -4% | -$28.2K | 0.53% | 51 |
|
|
2024
Q3 | $818K | Sell |
7,116
-1,191
| -14% | -$135K | 0.61% | 53 |
|
|
2024
Q2 | $879K | Buy |
8,307
+182
| +2% | +$18.3K | 0.64% | 54 |
|
|
2024
Q1 | $789K | Sell |
8,125
-31
| -0.4% | -$3.18K | 0.59% | 56 |
|
|
2023
Q4 | $824K | Sell |
8,156
-21
| -0.3% | -$2.03K | 0.63% | 55 |
|
|
2023
Q3 | $832K | Sell |
8,177
-296
| -3% | -$30K | 0.72% | 50 |
|
|
2023
Q2 | $854K | Sell |
8,473
-44
| -0.5% | -$4.4K | 0.69% | 52 |
|
|
2023
Q1 | $787K | Buy |
8,517
+828
| +11% | +$72.3K | 0.66% | 52 |
|
|
2022
Q4 | $701K | Buy |
7,689
+1,499
| +24% | +$126K | 0.59% | 52 |
|
|
2022
Q3 | $469K | Sell |
6,190
-847
| -12% | -$70.2K | 0.39% | 59 |
|
|
2022
Q2 | $593K | Sell |
7,037
-185
| -3% | -$16.2K | 0.5% | 53 |
|
|
2022
Q1 | $631K | Buy |
7,222
+536
| +8% | +$46.4K | 0.37% | 62 |
|
|
2021
Q4 | $579K | Buy |
6,686
+641
| +11% | +$53.2K | 0.32% | 65 |
|
|
2021
Q3 | $492K | Sell |
6,045
-332
| -5% | -$29.9K | 0.33% | 70 |
|
|
2021
Q2 | $577K | Buy |
6,377
+431
| +7% | +$38.4K | 0.38% | 71 |
|
|
2021
Q1 | $507K | Sell |
5,946
-119
| -2% | -$10.7K | 0.05% | 169 |
|
|
2020
Q4 | $574K | Buy |
6,065
+388
| +7% | +$33.9K | 0.06% | 185 |
|
|
2020
Q3 | $493K | Buy |
5,677
+172
| +3% | +$14.9K | 0.06% | 227 |
|
|
2020
Q2 | $481K | Sell |
5,505
-668
| -11% | -$57.7K | 0.06% | 177 |
|
|
2020
Q1 | $504K | Sell |
6,173
-34,772
| -85% | -$3.1M | 0.08% | 182 |
|
|
2019
Q4 | $3.88M | Sell |
40,945
-7,888
| -16% | -$708K | 0.51% | 55 |
|
|
2019
Q3 | $4.25M | Sell |
48,833
-6,490
| -12% | -$583K | 0.59% | 43 |
|
|
2019
Q2 | $5.05M | Sell |
55,323
-2,687
| -5% | -$227K | 0.58% | 49 |
|
|
2019
Q1 | $4.97M | Buy |
58,010
+1,723
| +3% | +$138K | 0.65% | 39 |
|
|
2018
Q4 | $4.31M | Buy |
56,287
+44,181
| +365% | +$3.44M | 0.53% | 49 |
|
|
2018
Q3 | $932K | Sell |
12,106
-58
| -0.5% | -$4.29K | 0.1% | 194 |
|
|
2018
Q2 | $828K | Sell |
12,164
-19
| -0.2% | -$1.31K | 0.11% | 204 |
|
|
2018
Q1 | $883K | Buy |
12,183
+1,372
| +13% | +$104K | 0.11% | 218 |
|
|
2017
Q4 | $813K | Buy |
+10,811
| New | +$816K | 0.1% | 179 |
|
Other funds holding NVS
Banco de Sabadell's NVS Position: Q1 2026 in Review
Banco de Sabadell reduced its Novartis (NVS) stake by 6.9% in Q1 2026, selling an estimated $59.6K and leaving 5,281 shares worth $796K. The position accounts for 0.53% of the portfolio, ranked #51.
Banco de Sabadell first reported a position in NVS in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.05M in Q2 2019. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Banco de Sabadell held 5,281 shares of Novartis worth $796K as of Q1 2026.
- Banco de Sabadell sold 389 Novartis shares in Q1 2026, an estimated $59.6K.
- Novartis made up 0.53% of Banco de Sabadell's portfolio in Q1 2026, its #51 holding.
- Banco de Sabadell first reported a position in Novartis in Q4 2017 and has held it in 34 quarters since.
- Banco de Sabadell's Novartis position peaked at $5.05M in Q2 2019.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Banco de Sabadell's 13F filing for Q1 2026, filed 8 May 2026.